Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEveryman Media Regulatory News (EMAN)

Share Price Information for Everyman Media (EMAN)

Share Price is delayed by 15 minutes
Get Live Data
35.20    -1.80 (-4.86%)
Bid:
36.00
Ask:
38.00
Spread: 2.00 (5.556%)
Market Cap: £32.18m
EMAN Live PriceLast checked at - London Stock Exchange

Intraday Everyman Media Share Chart

Trading Update

21 Jan 2022 07:00

RNS Number : 1612Z
Everyman Media Group PLC
21 January 2022
Β 

21 January 2022

Everyman Media Group PLC

("Everyman" the "Company" or the "Group")

Trading Update

Everyman Media Group plc (AIM: EMAN) is pleased to provide the following pre-audit trading update for the 52-week period ended 30 December 2021.

Β· Group revenue of Β£48.7m (2020: Β£24.2m), an increase of 101% year-on-year with 33 weeks trading, driven by strong admissions since re-opening

o Compares to 2020 which saw 10 weeks of normal trading, 17 weeks of disrupted trading and 25 weeks of full closure due to COVID-19 restrictions

o 2021 revenue was at 75% of the 2019 FY total (Β£65.0 m) despite having 19 weeks closed, particularly pleasing given 2019 was a record year for the Group

Β· Due to a better than expected performance in December, EBITDA1 is expected to be ahead of current market forecast at approximately Β£8.3m (2020: Β£1.1m loss).

Everyman now operates 36 venues, with one new venue at Borough Yards opened in the period, in December 2021. The total number of screens now operated by the Group is 119 (2020: 117).

Β 

Since re-opening on 17 May 2021 the Group has been EBITDA positive and operating cash generative each month. The outlook for the business is positive, reinforced by healthy admissions since re-opening and the Group's roll-out programme set to recommence in earnest with a committed pipeline of five new venues for the current financial year: Edinburgh, Plymouth, Durham, Marlow and Egham.

Β 

Alex Scrimgeour, Chief Executive Officer of Everyman Media Group PLC said:

"Robust admissions seen across our estate in the second half of the year proves that demand for entertainment at Everyman remains strong. I would like to say a special thank you to our incredible team for making it happen in such exceptionally difficult circumstances. We are increasingly optimistic about 2022 performance and excited by our new opening pipeline. We are looking forward to a stimulating and diverse slate of films which will entertain our Everyman community."

Β 

(1) Adjusted for pre-opening costs, acquisition expenses, depreciation, amortisation, share based payments and costs incurred directly related to Covid-19 . IFRS 16 has been applied.

Β 

For further information, please contact:

Everyman Media Group PLC

Β 

Alex Scrimgeour

Tel: +44 (0)20 3145 0500

ElizabethΒ Lake

Β 

Β 

Β 

Canaccord Genuity LimitedΒ (Nominated Adviser and Broker)

Tel: +44 (0)20 7523 8000

Bobbie Hilliam

Β 

Richard Andrews

Β 

Georgina McCooke

Β 

Β 

Β 

Alma PRΒ (Financial PR Advisor)

Tel:Β 020 3405 0205

Susie Hudson

Lily Soares Smith

Β 

Joe Pederzolli

Β 

Β 

Β 

Β 

Β 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014Β as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended) ("UK MAR").

Β 

Β 

About Everyman Media Group PLC:

Β 

Everyman is the fourth largest cinema business in the UK by number of venues, and is a premium, high growth leisure brand. Everyman operates a growing estate of venues across the UK, with an emphasis on providing first class cinema and hospitality.

Β 

Everyman is redefining cinema. It focuses on venue and experience as key competitive strengths, with a unique proposition:

Β· Intimate and atmospheric venues, which become a destination in their own right

Β· An emphasis on a strong quality food and drink menu prepared in-house

Β· A broad range of well-curated programming content, from mainstream and independent films to theatre and live concert streams, appealing to a diverse range of audiences

Β· Motivated and welcoming teams

Β 

For more information visitΒ http://investors.everymancinema.com/

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBKKBKCBKDNDB
Date   Source Headline
2nd Jun 20268:47 amRNSPDMR Shareholding
29th May 202611:56 amRNSPDMR Dealing
27th May 20269:23 amRNSPosting of Annual Report and Notice of AGM
21st May 20265:04 pmRNSPDMR Shareholding
6th May 20267:00 amRNSExercise of Options and Total Voting Rights
5th May 20267:00 amRNSExercise of Options and Total Voting Rights
5th May 20267:00 amRNSPDMR Dealing
28th Apr 20267:00 amRNSFull Year Results to 1 January 2026
21st Apr 20267:00 amRNSBoard Update and Notice of Results
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 202610:58 amRNSDirector/PDMR Shareholding
26th Mar 20265:08 pmRNSNotification of major holdings
26th Mar 20265:01 pmRNSNotification of major holdings
23rd Mar 20261:26 pmRNSDirector/PDMR Shareholding
16th Mar 20269:04 amRNSDirector/PDMR Shareholding
16th Mar 20269:04 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSGrant of Options
11th Mar 20267:00 amRNSGrant of Options
6th Mar 20267:00 amRNSDirector/PDMR Shareholding
19th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSBoard Appointments
27th Jan 20267:00 amRNSTrading Update
29th Dec 20257:00 amRNSBoard change
29th Dec 20257:00 amRNSBoard change
16th Dec 20252:47 pmRNSNotification of major holdings
15th Dec 20257:00 amRNSBoard change
10th Dec 20257:00 amRNSTrading Update
24th Sep 20257:02 amRNSChange of Options Terms
24th Sep 20257:01 amRNSAppointment of Non-Executive Director
24th Sep 20257:00 amRNSInterim Results
28th Jul 20257:00 amRNSTrading Update
19th Jun 20251:24 pmRNSResult of AGM
20th May 20257:00 amRNSPosting of Annual Report and Notice of AGM
9th May 20257:00 amRNSDirector / PDMR Shareholding
15th Apr 20257:01 amRNSGrant of Options
15th Apr 20257:00 amRNSPreliminary Results to 02 January 2025
2nd Apr 20257:00 amRNSNotice of Results
17th Jan 20257:00 amRNSTrading Update
25th Sep 20247:00 amRNSInterim Results
16th Aug 20247:00 amRNSExercise of Options and Total Voting Rights
1st Aug 20247:00 amRNSDirector/PDMR Shareholding
25th Jul 20247:00 amRNSTrading Update and Notice of Results
13th Jun 20243:45 pmRNSResult of AGM
17th May 20247:00 amRNSNotice of AGM
18th Apr 20249:17 amRNSDirector/PDMR Shareholding
17th Apr 20247:00 amRNSGrant of Options
16th Apr 20247:00 amRNSFinal Results to 28 December 2023
28th Mar 20247:00 amRNSNotice of Results and Investor Presentation
9th Feb 202412:45 pmRNSCorrection: Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.